BCIQ Profiles

Company Profile Report

Woodcock steps away from CDER for Operation Warp Speed; Marks back to CBER

Leadership shuffle at FDA to support government and company programs against COVID-19

In a major reorganization intended to better align FDA’s activities with the national effort to develop COVID-19 countermeasures, Janet Woodcock is temporarily stepping away from her position as director of FDA’s Center for Drug Evaluation and Research, and Peter Marks is stepping away from his role as lead of vaccines at Operation Warp Speed.

Woodcock

Read the full 555 word article

How to gain access

Continue reading with a
two-week free trial.